DAYTON, Ohio, April 12, 2018 /PRNewswire/ — Dr. Amol Soin, CEO of Soin Neuroscience, was recently reappointed to the state medical board of Ohio by Governor Kasich. Soin, whose term was to end in March 2018 is now reappointed to another 5 year term set to end in March 2023. Dr. Soin’s expertise in pain management has been helpful for Ohio that is currently managing the opioid crisis. “I am excited to be a part of the great work of the Ohio Medical Board as we continue to make progress in opioid prescribing habits and I look forward to working with the medical board on many other items over the next 5 years,” Dr Soin noted.
Dr. Amol Soin at the 20th annual ASIPP Awards. Pictured from left to right: Drs. Amol Soin, Laxmaiah Manchikanti, and Sunny Jha
eTN Chatroom for Readers (join us)
Additionally, last month Dr. Soin attended the 20th Annual American Society of Interventional Pain Physicians (ASIPP) meeting in Orlando, Florida. At that meeting, Dr. Soin won the award for “Outstanding Research” from the society. Dr. Soin was the only physician to receive the outstanding research award. “I am pleased to see that the work and research we do at Soin Neuroscience got recognized from one of the leading pain management societies in world. I look forward to continuing more research and development with our portfolio of products and with other groups we are working with,” Soin said. Dr. Soin was also recently elected president of the Society of Interventional Pain Management Surgery Centers and the ASIPP Foundation, which are affiliated organizations to the American Society of Interventional Pain Physicians.
About Soin Neuroscience:
Soin Neuroscience (SNI) is a pharmaceutical startup company based in Dayton, OH that specializes in treating pain and other neurological conditions. Its lead compound, TV1001SR, is entering late stage trials to treat systemic sclerosis and diabetic peripheral neuropathy. SNI also has multiple other compounds in development including a way to restore functional motor and cognitive function after ischemic stroke, a method to treat intensive care unit myopathy, and is working on an option to treat Huntington’s disease. The company was founded by Dr. Amol Soin who is also an inventor on most of the core technologies that are being developed. He can be reached at email@example.com.
View original content with multimedia:http://www.prnewswire.com/news-releases/dr-amol-soin-reappointed-to-the-state-medical-board-of-ohio-by-governor-kasich-300629403.html
SOURCE Soin Neuroscience
To post and circulate your own press release on FIR and the eTN Network please click here